Probucol treatment is associated with an ABCA1-independent mechanism of cholesterol efflux to lipid poor apolipoproteins from foam cell macrophages.

Hafiane, Anouar; Pisaturo, Alessandro; Ronca, Annalisa; Incerti, Matteo; Kiss, Robert S; Favari, Elda

Hafiane, Anouar; Pisaturo, Alessandro; Ronca, Annalisa; Incerti, Matteo; Kiss, Robert S; Favari, Elda.

Afiliação

Hafiane A; Research Institute, McGill University Health Center, Montreal, QC, Canada.
Pisaturo A; Research Institute, McGill University Health Center, Montreal, QC, Canada.
Ronca A; Department of Food and Drug, University of Parma, Italy.
Incerti M; Department of Food and Drug, University of Parma, Italy.
Kiss RS; Research Institute of the McGill University Health Center, Montreal, Canada and Department of Medicine, McGill University, Montreal, Canada.
Favari E; Department of Food and Drug, University of Parma, Italy.

BBA Adv ; 1: 100003, 2021.

Article em En | MEDLINE | ID: mdl-37082009

Palavras-chave

ABCA1; Apolipoprotein A-I; Cholesterol efflux; Cholesterol pool; High-density lipoprotein; Probucol

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: BBA Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google